Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
05/08/2008
Trade Name:
Desmopressin acetate Tablets, 0.1 mg and 0.2 mg
Generic Name or Proper Name (*):
desmopressin acetate
Indications Studied:
Determine the capacity of the kidney to concentrate urine in pediatric patients (Renal Concentration Capacity Test or RCCT) and management of primary nocturnal enuresis (PNE)
Label Changes Summary:
Efficacy in RCCT was evaluated in a single trial with children 3 to 18 years old Three studies evaluated efficacy in children 5 to 17 years old with PNE; an additional study evaluated efficacy in adolescents 12 to 17 years old Fluid intake should be adjusted downward in children to decrease the potential occurrence of water intoxication and hyponatremia Dosing information provided for children 3 to 18 years old for RCCT Dosing information provided for pediatric patients 6 years of age and older with PNE Tablet dosage and administration information provided for children with central diabetes insipidus Pharmacokinetics and pharmacodynamics were evaluated in children New indications and dosing regimen
PREA(P):
P
Sponsor:
Ferring
NNPS:
FALSE'
Therapeutic Category:
Urology
-
-